News-Medical.Net November 5, 2024
Hugo Francisco de Souza

Developed using data from diverse patient groups, AIRE’s advanced AI predicts heart disease risk and mortality with precision, giving clinicians tools for more targeted, long-term patient care.

In a recent study published in the journal The Lancet, researchers developed and validated a novel artificial intelligence (AI)-enhanced electrocardiography (ECG) model capable of leveraging patients’ medical histories and imaging results to accurately predict mortality and cardiovascular disease (CVD) risk.

While not the first attempt to use AI in disease and mortality prediction, this implementation overcomes previous models’ limitations of temporality, biological plausibility, and explainability, enabling it to generate predictions that can support actionable insights in clinical practice.

Study findings revealed that the novel model (named ‘AIRE’) can accurately predict all-cause mortality, ventricular...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Patient / Consumer, Provider, Survey / Study, Technology, Trends
‘Humphrey’ AI tool launched to streamline NHS and public services
Oracle shares jump 7% on involvement in AI infrastructure initiative that Trump will announce
Cofactor AI Launches Platform to Help Hospitals Fight Tidal Wave of Claims Denials and Announces $4 Million Seed Round
5 Healthcare AI Trends in 2025: Balancing Innovation and Patient Safety
Do We Need Humans in the Loop? A Novo Nordisk Exec Weighs In (Video)

Share This Article